Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pain, Postoperative 4Breast Neoplasms 4Agnosia 2Supratentorial Neoplasms 1Neoplasms 1Kidney Neoplasms 1ENT Cancers 1Cystic Adenomatoid Malformation of Lung, Congenital 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Bronchopulmonary Sequestration 1Bronchogenic Cyst 1Breast Surgery 1Breast Cancer Female 1Abdominal Pain 1

Interventions

Letrozole 2Bupivacaine 2pyrotinib 1exemestane 1abemaciclib 1Tumor Burden 1Thioctic Acid 1Tamoxifen 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sodium Chloride 1Ropivacaine 1Radiotherapy 1Radiofrequency Ablation 1Mastectomy, Segmental 1Mastectomy 1Mammaplasty 1Drug Therapy 1Dexmedetomidine 1Control Groups 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Cancer Female × Ropivacaine × 1 year × Clear all
NCT03360214 2025-06-15

PEMF and PEC Blocks in Mastectomy Reconstruction Patients

Columbia University

Phase 4 Completed
60 enrolled 11 charts
Breast

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡